Table 1 Clinical data of 23 patients treated with induction chemotherapy of homoharringtonine and cytarabine.
Case | Sex/year | History of MDS(+/-) | WBC (×109) | BM leukemic cells(%) | karyotype | FAB subtype |
|---|---|---|---|---|---|---|
1 | F/60 | - | 7.3 | 58.0 | t(7;11), -21/-17 | M2 |
2 | M/70 | + | 2.7 | 31.0 | - | M1 |
3 | M/61 | - | 102.0 | 76.0 | - | M5 |
4 | F/70 | - | 60.4 | 93.0 | - | M4 |
5 | M/75 | + | 1.5 | 81.0 | Normal | M6 |
6 | M/60 | + | 0.7 | 38.0 | - | M2 |
7 | F/60 | - | 1.3 | 70.5 | Normal- | M5 |
8 | M/61 | - | 1.2 | 60.0 | Normal | M5 |
9 | M/71 | - | 58.9 | 76.0 | - | M4 |
10 | M/75 | + | 24.3 | 20.0 | Normal | M4 |
11 | M/63 | - | 1.3 | 64.0 | - | M5 |
12 | F/60 | + | 31.8 | 48.0 | t(11;19) | M2 |
13 | M/74 | - | 263.3 | 85.0 | - | M4 |
14 | M/70 | - | 6.2 | 96.0 | +1(?20q-) | M1 |
15 | M/69 | - | 21.7 | 76.0 | 7q-,11q- | M1 |
16 | M/72 | - | 15.8 | 85.0 | Normal | M5 |
17 | F/70 | + | 1.5 | 20.0 | - | M4 |
18 | F/72 | - | 2.1 | 31.0 | - | M7 |
19 | F/66 | - | 3.0 | 46.0 | - | M6 |
20 | M/71 | - | 1.1 | 35.0 | - | M2 |
21 | M/84 | - | 11.1 | 72.0 | Normal | M1 |
22 | M/72 | - | 1.3 | 66.0 | - | M5 |
23 | F/70 | + | 4.0 | 35.0 | - | M5 |